UK regulator advises US not to rush into third party review
This article was originally published in Clinica
Executive Summary
US medical device manufacturers regard the European Directives as the best of all possible systems, to which the US must aspire - quickly. It is not and don't, Alan Kent, chief executive of the UK Medical Devices Agency, advised a Food and Drug Law seminar in Washington, DC, last month.